alexa Data Standards are Needed to Move Translational Medicin
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Commentary

Data Standards are Needed to Move Translational Medicine Forward

Ann Marie Martin1*, Nathalie Seigneuret1, Ferran Sanz2,3 and Michel Goldman1

1Innovative Medicines Initiative, Belgium

2Research Programme on Biomedical Informatics (GRIB), IMIM, DCEXS, Pompeu Fabra University, Barcelona, Spain

3Spanish Institute of Bioinformatics (INB), Spain

*Corresponding Author:
Ann Marie Martin
Principal Scientific Manager Knowledge Management
Innovative Medicines Initiative, Postal mail: IMI JU
TO 56, 6th floor, B-1049 Brussels, Spain
E-mail: [email protected]

Received Date: October 07, 2013; Accepted Date: November 11, 2013; Published Date: November 13, 2013

Citation: Martin AN, Seigneuret N, Sanz F, Goldman M (2013) Data Standards are Needed to Move Translational Medicine Forward. Transl Med 3:119. doi: 10.4172/2161-1025.1000119

Copyright: © 2013 Martin AN et al., This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Data standards and data management procedures help to overcome the data and information management challenges in translational medicine for the purpose of deriving new results and knowledge. In regulated medicine, the reason for using data standards is to facilitate the review, verification and replication of the research results as part of a drug or device approval process. Additionally, data standards are indispensable in enabling ongoing safety and quality surveillance of marketed products. Data management procedures must be adhered to and documented to ensure the integrity and verifiability of the research results. Lack of data standards and appropriate data management procedures and absence of good documentation make it hard and labour intensive to combine data in order to answer new research questions. Fortunately, many data standards are available which are well-recognized and certified and which can be readily applied. We argue that it does not matter which data standards are chosen as long as well-recognized data standards are used and the data management procedures are documented and referenced in a citable way in the write-up of the study results and publications. Data could be used in far more powerful and efficient ways when one observes these principles. For this reason, the Innovative Medicines Initiative (IMI) is actively encouraging its projects to both use and contribute to data standards.

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords